Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 25.05.2026 2 Ann Intern Med 6 BMC Ophthalmol 1 BMC Pediatr 13 Diabet Med 10 Diabetes 25 Diabetes Care 6 Diabetes Obes Metab 4 Diabetologia 1 Hypertension 1 Invest Ophthalmol Vis Sci 1 J Am Coll Cardiol 1 J Autoimmun 3 J Clin Endocrinol Metab 3 J Clin Invest 2 J Diabetes Complications 2 JAMA 3 Metabolism 1 Nature 1 Ophthalmol Retina 1 Ophthalmology 1 PLoS Med 9 PLoS One 1 Retina 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. KARAGIANNIS T, Avgerinos I, Tsapas A
   In adults with T2D and ASCVD, tirzepatide was noninferior to dulaglutide for a composite CV outcome at a median 4 y.
   Ann Intern Med. 2026;179:JC53.
   PubMed         Abstract available
   
   
2. ESCUDERO C, Havranek K, Martinez Cruz M, Batch B, et al
   Endocrinology: What You May Have Missed in 2025.
   Ann Intern Med. 2026;179.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

3. LI Y, Xu Y, Ren Q, Pan Z, et al
   Impaired pupillary sensitivity in diabetic patients and correlation with visual outcome in cataract surgery.
   BMC Ophthalmol. 2026 May 22. doi: 10.1186/s12886-026-04894.
   PubMed         Abstract available
   
   
4. WANG J, Ma Y
   Active-fluidics versus gravity-fluidics system in phacoemulsification for type 2 diabetes mellitus without diabetic retinopathy: a retrospective observational study.
   BMC Ophthalmol. 2026 May 20. doi: 10.1186/s12886-026-04927.
   PubMed         Abstract available
   
   
5. GHADAI KK, Nayak SK, Senapati BR
   A clinically interpretable deep learning pipeline for diabetic retinopathy classification using EfficientNet, advanced data augmentation and GradCAM.
   BMC Ophthalmol. 2026 May 19. doi: 10.1186/s12886-026-04897.
   PubMed         Abstract available
   
   
6. YU SH, Cho J, Park SM, Kim CG, et al
   Short-term treatment outcomes of the ranibizumab biosimilar CKD-701 for vitreous hemorrhage secondary to proliferative diabetic retinopathy.
   BMC Ophthalmol. 2026 May 18. doi: 10.1186/s12886-026-04887.
   PubMed         Abstract available
   
   
7. BAYBORA H, Ozal E, Ozal SA
   Clinical real-world data evaluation: comparison of central macular thickness after anti-VEGF treatment in diabetic macular edema patients treated with or without topical anti-glaucoma agents.
   BMC Ophthalmol. 2026 May 19. doi: 10.1186/s12886-026-04925.
   PubMed         Abstract available
   
   
8. ALSHIMALI R, Jamal L, Khorsheed S, Maqwar Z, et al
   Efficacy of topical nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of diabetic macular edema (DME): a systematic review and meta-analysis.
   BMC Ophthalmol. 2026 May 16. doi: 10.1186/s12886-026-04910.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

9. KORDONOURI O, Niemeyer M, Marquardt E, Berge TVD, et al
   Correction: Protection through early knowledge: clinical onset of type 1 diabetes in children and adolescents with and without early T1D detection programmes.
   BMC Pediatr. 2026;26:447.
   PubMed        
   
   

   
   Diabet Med

10. PHAM S, Qian H, Elhindi J, Byrnes O, et al
    Association between gestational diabetes, ethnicity and migrant length of residence: An Australian cohort study.
    Diabet Med. 2026 May 15:e70359. doi: 10.1111/dme.70359.
    PubMed         Abstract available
    
    
11. RADLEY A, Beer L, Farre A, Rauchhaus P, et al
    Detection of prediabetes and undiagnosed type 2 diabetes in underserved communities using community pharmacy point-of-care testing: A prospective feasibility study.
    Diabet Med. 2026 May 15:e70368. doi: 10.1111/dme.70368.
    PubMed         Abstract available
    
    
12. STOCKER R, Russell S, Taylor GS, Witham MD, et al
    What barriers need to be removed to incorporate resistance exercise into the lives of older adults with long-term diabetes and prefrailty? A deductive framework analysis using the Capability, Opportunity, Motivation and Behaviour (COM-B) behavioural s
    Diabet Med. 2026 May 16:e70367. doi: 10.1111/dme.70367.
    PubMed         Abstract available
    
    
13. HOUSBY H, Kaur A, Godsland I, Wylie T, et al
    Type 1 diabetes stigma: A UK survey of adults living with type 1 diabetes.
    Diabet Med. 2026 May 18:e70365. doi: 10.1111/dme.70365.
    PubMed         Abstract available
    
    
14. PAL AW, Chong WL, Huri HZ, Ratnasingam J, et al
    Continuous glucose monitoring in type 2 diabetes: Evidence for glycaemic metrics and patient-reported outcomes.
    Diabet Med. 2026 May 18:e70360. doi: 10.1111/dme.70360.
    PubMed         Abstract available
    
    
15. CHAUDHRY UAR, Chandrasekaran L, Rudnicka AR
    Response to letter: 'Towards equitable implementation of AI-assisted screening for diabetic retinopathy: Perspectives on digital literacy, trust and system readiness in developing countries'.
    Diabet Med. 2026 May 19:e70345. doi: 10.1111/dme.70345.
    PubMed        
    
    
16. PUTRA BJ, Rohmiati
    Towards equitable implementation of AI-assisted screening for diabetic retinopathy: Perspectives on digital literacy, trust and system readiness in developing countries.
    Diabet Med. 2026 May 19:e70325. doi: 10.1111/dme.70325.
    PubMed        
    
    
17. PRICE J, Deatrick JA, Curran G, Yang CL, et al
    Implementing a behavioural intervention for paediatric type 1 diabetes: Key informant perspectives of multilevel barriers and facilitators.
    Diabet Med. 2026 May 20:e70366. doi: 10.1111/dme.70366.
    PubMed         Abstract available
    
    
18. KELLY M, Saluja S, Ellis HL, Jamil S, et al
    A systematic review and meta-analysis of the relative benefit of dual versus single oral hypoglycaemic therapy following diagnosis with type 2 diabetes (T2D).
    Diabet Med. 2026 May 21:e70337. doi: 10.1111/dme.70337.
    PubMed         Abstract available
    
    
19. BREEN C, Powell S, Patterson E, Finnegan M, et al
    Language matters: Guidance for person-centred diabetes communication in Ireland.
    Diabet Med. 2026 May 21:e70364. doi: 10.1111/dme.70364.
    PubMed         Abstract available
    
    
20. HO F, Kyi M, Fourlanos S, Colman PG, et al
    A retrospective sub-study of perioperative glycaemia and insulin treatment for hospital inpatients at a quaternary centre from the specialist treatment of inpatients: Caring for diabetes in surgery trial (STOIC-D Surgery).
    Diabet Med. 2026 May 21:e70370. doi: 10.1111/dme.70370.
    PubMed         Abstract available
    
    
21. STUCKEY HL, Cooke D, Knehans AC, Skinner TC, et al
    Psychological research in eating disorders/disordered eating in type 1 diabetes: A systematic review using the NIH stage model for behavioural intervention development.
    Diabet Med. 2026 May 21:e70369. doi: 10.1111/dme.70369.
    PubMed         Abstract available
    
    
22. JENDLE J, Picado N, Bulhosa C, Janssen M, et al
    Cost-effectiveness of control-IQ automated insulin delivery in adults with type 1 diabetes in Sweden.
    Diabet Med. 2026 May 21:e70355. doi: 10.1111/dme.70355.
    PubMed         Abstract available
    
    

    
    Diabetes

23. NAIR AK, Traurig M, Muller YL, Anup D, et al
    Human iPSC-Based Modeling Identifies Epigenetic Regulation at the KCNQ1 Locus During Early Islet Development That Contributes to Lower beta-Cell Mass.
    Diabetes. 2026;75:1038-1049.
    PubMed         Abstract available
    
    
24. ONIZUKA S, Shinjo T, Ishikado A, Wu IH, et al
    Protection Against Periodontitis by Improving Mitochondrial Function in Diabetes.
    Diabetes. 2026 May 15:db250849. doi: 10.2337/db25-0849.
    PubMed         Abstract available
    
    
25. ZHU Z, Qiu A, Wang N, Zhu Z, et al
    cGAS-STING Pathway Mediates Retinal Pigmental Epithelial Dysfunction in Diabetic Retinopathy.
    Diabetes. 2026 May 18:db250128. doi: 10.2337/db25-0128.
    PubMed         Abstract available
    
    
26. SLIKA A, Noureddine M, Jomaa D, Abboud EE, et al
    Growth Differentiation Factor-15 in Diabetic Kidney and Cardiovascular Disease: Pathogenic Driver or Protective Modulator.
    Diabetes. 2026 May 18:db260133. doi: 10.2337/db26-0133.
    PubMed         Abstract available
    
    
27. KOPRIVICA I, Jonic N, Dimitrijevic M, Jevtic B, et al
    Activation of Intestinal Type 3 Innate Lymphoid Cells and Regulatory T Cells Through Free Fatty Acid Receptor 2 Ameliorates Type 1 Diabetes in Mice.
    Diabetes. 2026 May 18:db250742. doi: 10.2337/db25-0742.
    PubMed         Abstract available
    
    
28. LV F, Tang Y, Kou L
    Comment on Uddin et al. Interpreting Retinal Hypoxia in Early Diabetes.
    Diabetes. 2026;75:e15-e16.
    PubMed        
    
    
29. PAGE B
    Diabetes Spotlight: Jonathan Campbell, PhD-Understanding Incretins Through alpha-Cell-to-beta-Cell Communication and Receptor Signaling Pathways.
    Diabetes. 2026;75:877-878.
    PubMed        
    
    
30. UDDIN MI
    Response to Comment on Uddin et al. Interpreting Retinal Hypoxia in Early Diabetes.
    Diabetes. 2026;75:e17-e18.
    PubMed        
    
    
31. JANKAUSKAS SS, Varzideh F, Santulli G
    Hippo-YAP Signaling Drives Epigenetic Vulnerability in the Diabetic Heart via the miR-22-3p-SIRT1 Axis: Linking Metabolic Stress to Chromatin Control.
    Diabetes. 2026;75:882-884.
    PubMed        
    
    
32. ALI A, Boyne M, Othman A, Kamli-Salino S, et al
    Myeloid Cell Protein Tyrosine Phosphatase 1B Drives Retinal Neurodegeneration in Diabetic Mice.
    Diabetes. 2026 May 21:db250904. doi: 10.2337/db25-0904.
    PubMed         Abstract available
    
    

    
    Diabetes Care

33. LIU B, Sun Q
    Response to Comment on Liu et al. Low-Carbohydrate Diets of Varying Macronutrient Quality and Risk of Type 2 Diabetes in Three U.S. Prospective Cohort Studies. Diabetes Care 2025;48:2095-2102.
    Diabetes Care. 2026;49:e103-e104.
    PubMed        
    
    
34. MANN JFE, Jeppesen OK, Belmar N, McGuire DK, et al
    Response to Comment on Mann et al. Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial. Diabetes Care 2026;49:257-265.
    Diabetes Care. 2026;49:e111-e112.
    PubMed        
    
    
35. KUO S, Ye W, McEwen LN, Villatoro Santos C, et al
    Comment on Echouffo-Tcheugui et al. Is the Current Lifestyle Modification Approach to Diabetes Prevention in the U.S. a Success? Diabetes Care 2025;48:863-870.
    Diabetes Care. 2026;49:e113.
    PubMed        
    
    
36. DENG J
    Comment on Pop-Busui et al. Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure. Diabetes Care 2025;48:2145-2153.
    Diabetes Care. 2026;49:e116.
    PubMed        
    
    
37. YOUNG KG, McGovern AP, Hopkins R, Jansz TT, et al
    Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study.
    Diabetes Care. 2026;49:1115-1123.
    PubMed         Abstract available
    
    
38. CORRAO S
    Comment on Sattar et al. Weight Reduction With Tirzepatide Varied Meaningfully by Baseline HbA1c Category in Adults With Overweight or Obesity and Type 2 Diabetes in SURMOUNT-2. Diabetes Care 2025;48:e136-e137.
    Diabetes Care. 2026;49:e114-e115.
    PubMed        
    
    
39. TEUFEL F, Theilmann M, Marcus ME, Sulola MA, et al
    Comparing Approaches for Deriving Diabetes Care Cascades to Inform Policy: A Cross-sectional Analysis Using National Data From 88 Countries.
    Diabetes Care. 2026;49:1106-1114.
    PubMed         Abstract available
    
    
40. SHAH S, Hasenbohler A, Javaux G, Payen de la Garanderie M, et al
    Food Coloring Additives and Incidence of Type 2 Diabetes in the NutriNet-Sante Prospective Cohort.
    Diabetes Care. 2026;49:1067-1077.
    PubMed         Abstract available
    
    
41. MARTYN-NEMETH P, Duffecy J, Steffen AD, Baron KG, et al
    Sleep Optimization to Improve Glycemic Targets in Adults With Type 1 Diabetes: A Randomized Controlled Parallel Intervention Trial.
    Diabetes Care. 2026 May 18:dc260273. doi: 10.2337/dc26-0273.
    PubMed         Abstract available
    
    
42. DELANEY PWJ, Hayes E, Rajan R, Smith GJ, et al
    Reduced Prevalence of Impaired Awareness of Hypoglycemia Over Two Decades in Population-Based Samples of Youth With Type 1 Diabetes.
    Diabetes Care. 2026 May 15:dc260044. doi: 10.2337/dc26-0044.
    PubMed         Abstract available
    
    
43. BERGENSTAL RM, Crandall JP, Rosin SP, Butera NM, et al
    Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized Trial.
    Diabetes Care. 2026;49:981-989.
    PubMed         Abstract available
    
    
44. KOK N, Williamson WT, Lee JM, Gaynanova I, et al
    Impact of Missing Data and Monitoring Duration on Downstream Analyses in Continuous Glucose Monitoring.
    Diabetes Care. 2026;49:1031-1039.
    PubMed         Abstract available
    
    
45. KLEIN KR, Menacher A, Buse JB, Mann JFE, et al
    Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis.
    Diabetes Care. 2026;49:999-1005.
    PubMed         Abstract available
    
    
46. WILD SH
    Young Age at Onset of Hypertension: A Potentially Modifiable Risk Factor for Diabetes Complications.
    Diabetes Care. 2026;49:937-939.
    PubMed        
    
    
47. THIRUMALAI A, Hirsch IB
    Glycemic Trends From Continuous Glucose Monitoring With DPP-4 Inhibitor Therapy in Patients With Type 2 Diabetes-Redefining the Role of an Overlooked Agent.
    Diabetes Care. 2026;49:940-942.
    PubMed        
    
    
48. EGAN AM, Vella A
    More Than Stress Hyperglycemia: Acute Pancreatitis as a Prelude to Diabetes.
    Diabetes Care. 2026;49:943-945.
    PubMed        
    
    
49. SHI J, Ji G, Zhang Z, Zhang L, et al
    Comment on Liu et al. Low-Carbohydrate Diets of Varying Macronutrient Quality and Risk of Type 2 Diabetes in Three U.S. Prospective Cohort Studies. Diabetes Care 2025;48:2095-2102.
    Diabetes Care. 2026;49:e101-e102.
    PubMed        
    
    
50. LI S
    Comment on Mann et al. Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial. Diabetes Care 2026;49:257-265.
    Diabetes Care. 2026;49:e109-e110.
    PubMed        
    
    
51. SCHUMACHER LM, Bauerle Bass S, Ard J, Rubin DJ, et al
    Response to Comment on Schumacher et al. Addressing the Feasibility Gap in Shared Decision-Making for Obesity and Type 2 Diabetes Care.
    Diabetes Care. 2026;49:e99-e100.
    PubMed        
    
    
52. THAI NQN, Chun LF, Newton KP, Bandoli G, et al
    Response to Comment on Thai et al. Longitudinal Analysis of Liver Chemistry Trajectories and Risk of Type 2 Diabetes in Children With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Cohort Study. Diabetes Care 2026;49:598-606.
    Diabetes Care. 2026;49:e96-e97.
    PubMed        
    
    
53. HONG AT, Luu IY, Armstrong DG, Tan TW, et al
    Response to Comment on Hong et al. Differential Effect of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lower-Extremity Amputation Outcomes in Type 2 Diabetes: A Nationwide Retrospective Cohort Study. Diabetes Care 2025;48:1728-1736.
    Diabetes Care. 2026;49:e107-e108.
    PubMed        
    
    
54. RAGOZZINO G, Mattera E
    Comment on Schumacher et al. Shared Decision-Making Feasibility Gap in Obesity and Type 2 Diabetes Care.
    Diabetes Care. 2026;49:e98.
    PubMed        
    
    
55. BROWN SM, Middelbeek RJ, Brown FM, Patti ME, et al
    Comment on Van Der Meer et al. Impact of Metabolic Bariatric Surgery on Weight Loss and Glycemic Control in Adults With Type 1 Diabetes: A Multicenter Retrospective Cohort Study. Diabetes Care 2026;49:658-663.
    Diabetes Care. 2026;49:e119-e120.
    PubMed        
    
    
56. GARCIA DE LUCAS MD, Lopez Carmona MD
    Comment on Hong et al. Differential Effect of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lower-Extremity Amputation Outcomes in Type 2 Diabetes: A Nationwide Retrospective Cohort Study. Diabetes Care 2025;48:1728-1736.
    Diabetes Care. 2026;49:e105-e106.
    PubMed        
    
    
57. ZHOU Y, Xing H
    Comment on Thai et al. Longitudinal Analysis of Liver Chemistry Trajectories and Risk of Type 2 Diabetes in Children With Metabolic Dysfunction- Associated Steatotic Liver Disease: A Multicenter Cohort Study. Diabetes Care 2026;49:598-606.
    Diabetes Care. 2026;49:e94-e95.
    PubMed        
    
    

    
    Diabetes Obes Metab

58. ODAI RL, Tsagli DD, Alchaer A, Sajjad L, et al
    Cardiovascular Outcomes With SGLT-2 Inhibitors in Patients With Type 2 Diabetes and Obstructive Sleep Apnoea: A Real-World Analysis.
    Diabetes Obes Metab. 2026 May 21. doi: 10.1111/dom.70909.
    PubMed        
    
    
59. ROSENSTOCK J, Mathieu C, Feinberg JB, Rao P, et al
    Simplified Switching to Once-Weekly Insulin Icodec Without an Initial One-Time Additional Dose Versus Once-Daily Insulin Glargine U100 in Basal Insulin-Treated Type 2 Diabetes (ONWARDS 10): A Randomised Controlled Trial.
    Diabetes Obes Metab. 2026 May 21. doi: 10.1111/dom.70813.
    PubMed         Abstract available
    
    
60. DEN BROK EJ, Svensson CH, Olsen MT, Dimitropoulou NM, et al
    Randomised Controlled Multicentre Trial to Investigate the Effectiveness of a Mobile Artificial Intelligence Solution for Diabetes Adapted Care: The MELISSA Trial Protocol.
    Diabetes Obes Metab. 2026 May 19. doi: 10.1111/dom.70879.
    PubMed         Abstract available
    
    
61. DENG C, Fan W, Xie Y, Tang X, et al
    Health Inequities in Older Adults With Type 1 Diabetes: A Nationwide Registry Analysis of Sociodemographic and Clinical Profiles for Glycaemic Control and Complications.
    Diabetes Obes Metab. 2026 May 18. doi: 10.1111/dom.70833.
    PubMed         Abstract available
    
    
62. MATHIEU C, Cherubini V, Kapellen T, de Villar NGP, et al
    Advancing Early-Stage Type 1 Diabetes Care: Future Focused Pathways for Identification, Screening, Diagnosis, and Monitoring.
    Diabetes Obes Metab. 2026 May 18. doi: 10.1111/dom.70688.
    PubMed         Abstract available
    
    
63. ZOU Y, Su Y, Chen Y, Duan X, et al
    Associations of Social Determinants and Lifestyle Factors With Incidence and Dynamic Progression of Type 2 Diabetes in the Chinese Population.
    Diabetes Obes Metab. 2026 May 17. doi: 10.1111/dom.70877.
    PubMed         Abstract available
    
    

    
    Diabetologia

64. DEGROOTE L, Chrzanowski J, Lemaitre P, Wouters A, et al
    GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection.
    Diabetologia. 2026 May 18. doi: 10.1007/s00125-026-06750.
    PubMed         Abstract available
    
    
65. ABITBOL A, Riddell MC, Peers S, Simonson E, et al
    Effect of somatostatin receptor 2 antagonism on glucagon counterregulation during a hyperinsulinaemic euglycaemic-hypoglycaemic glucose clamp in adult men and women with long-standing type 1 diabetes: a randomised crossover phase 1 study.
    Diabetologia. 2026 May 21. doi: 10.1007/s00125-026-06748.
    PubMed         Abstract available
    
    
66. SAJJADI SF, Sacre JW, Kowlessur S, Soderberg S, et al
    Age-related patterns of cardiometabolic risk factors for complications in type 2 diabetes.
    Diabetologia. 2026 May 22. doi: 10.1007/s00125-026-06753.
    PubMed         Abstract available
    
    
67. CHEPULIS L, Gan H, Simmons D, Rodrigues M, et al
    Correction: SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic population.
    Diabetologia. 2026 May 22. doi: 10.1007/s00125-026-06752.
    PubMed        
    
    

    
    Hypertension

68. LIU T, Vonen HD, Henao R, Pencina MJ, et al
    Lifetime Adverse Pregnancy Outcome History and Cardiovascular Risk.
    Hypertension. 2026 Mar 20. doi: 10.1161/HYPERTENSIONAHA.125.25916.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

69. HUANG Y, Gui M, Kong X, Li T, et al
    Longitudinal Multi-Omics Profiling of Aqueous Humor Implicates GALNS Depletion as a Pro-Fibrotic Mediator of Anti-VEGF Therapy in PDR.
    Invest Ophthalmol Vis Sci. 2026;67:43.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

70. SASEEN JJ, Soffer DE, Wilkins JT
    New Dyslipidemia Guideline Expands Treatment Options and Risk Assessment in Patients With Diabetes and Chronic Kidney Disease.
    J Am Coll Cardiol. 2026;87:2573-2575.
    PubMed        
    
    

    
    J Autoimmun

71. SORGJERD EP, Hals IK, Lonnum BE, Edstorp J, et al
    Impacts of HLA-DR3DQ2 and HLA-DR4DQ8 haplotypes singly and combined on autoimmunity, phenotype and comorbidity in patients with Latent Autoimmune Diabetes in the adult. Results from the HUNT and ESTRID studies.
    J Autoimmun. 2026;161:103576.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

72. VARALDO E, Lustenberger S, Atila C, Monnerat S, et al
    Bone turnover in arginine vasopressin deficiency: a comparative study with primary polydipsia and healthy controls.
    J Clin Endocrinol Metab. 2026;111:e1523-e1531.
    PubMed         Abstract available
    
    
73. MAHADEVAN A, Vosooghi A, Arora JS, Kumar RS, et al
    GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization.
    J Clin Endocrinol Metab. 2026;111:1604-1612.
    PubMed         Abstract available
    
    
74. CHACKO SR, Sharma SS, Ahmadian S, Saini J, et al
    Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2026;111:1613-1627.
    PubMed         Abstract available
    
    

    
    J Clin Invest

75. HEROLD KC, Evans-Molina C
    New and emerging therapies in type 1 diabetes mellitus.
    J Clin Invest. 2026;136:e205520.
    PubMed         Abstract available
    
    
76. URANO F, Marshall BA, Hurst S, Robichaux-Viehoever A, et al
    Phase II trial of sodium phenylbutyrate and taurursodiol in Wolfram syndrome.
    J Clin Invest. 2026;136:e198519.
    PubMed         Abstract available
    
    
77. WANG Y, Huang H, Shao F, Eshwaran R, et al
    Disrupting VE-cadherin Y685 phosphorylation inhibits development of experimental diabetic and prediabetic retinopathy.
    J Clin Invest. 2026;136:e195048.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

78. DRINKWATER JJ, Chan C, Maxwell S, Davis WA, et al
    The longitudinal relationship between carotid arterial disease and retinopathy complicating type 2 diabetes: The Fremantle diabetes study phase II.
    J Diabetes Complications. 2026;40:109344.
    PubMed         Abstract available
    
    
79. ZHANG Y, Yang X, Zhang Y, Shang M, et al
    Risk factors and serum amino acid metabolic profiles of patients with type 1 diabetes and concomitant mild cognitive impairment: A cross-sectional study.
    J Diabetes Complications. 2026;40:109332.
    PubMed         Abstract available
    
    

    
    JAMA

80. FELTON JL, Sims EK
    A New Type 1 Diabetes Diagnosis Paradigm.
    JAMA. 2026 May 21. doi: 10.1001/jama.2026.6454.
    PubMed        
    
    
81. WINKLER C, Friedl N, Abt R, Ackermann K, et al
    Screening Children for Early-Stage Type 1 Diabetes.
    JAMA. 2026 May 21. doi: 10.1001/jama.2026.6085.
    PubMed         Abstract available
    
    

    
    Metabolism

82. LIU J, Xu W, Yan W, Qin Y, et al
    Islet inflammatory macrophages drive MSC loss and multiple interactions involved in beta-cell adaptation during diabetes.
    Metabolism. 2026;181:156636.
    PubMed         Abstract available
    
    
83. GARCIA-GAVILAN JF, Paz-Graniel I, Salas-Salvado J
    Reply to letter to the editor: Metabolomic signatures of type 2 diabetes and mortality: Methodological considerations and unresolved questions.
    Metabolism. 2026 May 18:156649. doi: 10.1016/j.metabol.2026.156649.
    PubMed        
    
    
84. ZHANG H, Yue T, Wang S, Shi J, et al
    A multi-omics atlas of multisystem complications in type 2 diabetes reveals molecular signatures and improves risk prediction.
    Metabolism. 2026 May 20:156650. doi: 10.1016/j.metabol.2026.156650.
    PubMed         Abstract available
    
    

    
    Nature

85. LISKIEWICZ D, Novikoff A, Khalil A, Akindehin S, et al
    Publisher Correction: GLP-1R-GIPR-PPARalpha/gamma/delta quintuple agonism corrects obesity and diabetes in mice.
    Nature. 2026 May 18. doi: 10.1038/s41586-026-10619.
    PubMed        
    
    

    
    Ophthalmol Retina

86. KRIVIT JR, Wang KY, Andrade Romo JS, Nirmalan A, et al
    Proliferative Diabetic Retinopathy Incidence and Outcomes in Younger Patients from 1970-2019.
    Ophthalmol Retina. 2026 May 19:S2468-6530(26)00218.
    PubMed        
    
    

    
    Ophthalmology

87. SAMPANI K, Ashraf M, Jacoba CM, Tirukovela S, et al
    Modifiable factors associated with Diabetic Retinal Disease and Retinal Neural Layer Thickness in Youth with Type 1 Diabetes.
    Ophthalmology. 2026 May 19:S0161-6420(26)00363.
    PubMed         Abstract available
    
    

    
    PLoS Med

88. CHRZANOWSKI J, Walicka M, Burzynski J, Zaras M, et al
    Semaglutide-associated risk of nonarteritic anterior ischemic optic neuropathy in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies.
    PLoS Med. 2026;23:e1005064.
    PubMed         Abstract available
    
    

    
    PLoS One

89. LI A, Zhou Z, Chen X, Liu Y, et al
    Impact of cardiometabolic index on long-term mortality in young adults with type 2 diabetes mellitus.
    PLoS One. 2026;21:e0348952.
    PubMed         Abstract available
    
    
90. FINK A, Buchmann N, Tegeler C, Steinhagen-Thiessen E, et al
    Correction: Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance in a community-dwelling elderly population in Germany.
    PLoS One. 2026;21:e0349833.
    PubMed         Abstract available
    
    
91. LI Y, Liu W, Zeng X, Cui J, et al
    Prediabetes, diabetes, and the risk of progression to diabetes among working population in Beijing-the Tongren HealthCare Study.
    PLoS One. 2026;21:e0343993.
    PubMed         Abstract available
    
    
92. DENG W, Zhang S, Zhang Y, Wan Q, et al
    The association between platelet-to-albumin ratio and diabetic peripheral neuropathy: A cross-sectional study in the Chinese population.
    PLoS One. 2026;21:e0348402.
    PubMed         Abstract available
    
    
93. HEREDIA NI, Thornton LR, Guevara DC, Williams N, et al
    Impact of a culinary medicine intervention on diet and health metrics in patients with type 2 diabetes and elevated body mass index.
    PLoS One. 2026;21:e0347040.
    PubMed         Abstract available
    
    
94. YONEKURA Y, Tanno K, Higashiyama A, Okuda N, et al
    Association between obesity and medical expenditures among Japanese adults treated for diabetes: A secondary analysis.
    PLoS One. 2026;21:e0349416.
    PubMed         Abstract available
    
    
95. BAI L, Li P, Zhao L
    Network toxicology and bioinformatics analysis predict potential molecular targets and mechanisms by which sevoflurane and propofol influence type 2 diabetes mellitus.
    PLoS One. 2026;21:e0349565.
    PubMed         Abstract available
    
    
96. FANG G, Gong W, Xia L, Li L, et al
    The mediating roles of personal mastery and health-promoting behaviors in the relationship between self-regulatory fatigue and quality of life among patients with type 2 diabetes mellitus.
    PLoS One. 2026;21:e0349561.
    PubMed         Abstract available
    
    
97. KHATTAK MI, Rehman K, Afaq S, Butt SS, et al
    Engaging communities through participatory learning action for the control and prevention of diabetes: A protocol for the Process Evaluation of the EMPOWER-D trial in Pakistan and Afghanistan.
    PLoS One. 2026;21:e0345231.
    PubMed         Abstract available
    
    

    
    Retina

98. SALADINO A, Arrigo A, Koutsidis C, Eduardo Stanga SF, et al
    Value of Combining Ultra-widefield Fundus Fluorescein Angiography (UWF-FFA) with 130 degrees Single-scan Ultra-widefield Optical Coherence Tomography Angiography (UWF-OCTA) in Retinal Vasculopathies.
    Retina. 2026 Jan 30. doi: 10.1097/IAE.0000000000004797.
    PubMed         Abstract available
    
    

    
    Transplantation

99. FRIDELL JA, Dunn TB, Oram RA, Sadhu AR, et al
    The Elusive Definition of Type 2 Diabetes in the Context of Pancreas Transplantation: Summary of the International Pancreas and Islet Transplantation Association Pre-Congress Meeting.
    Transplantation. 2026 May 18. doi: 10.1097/TP.0000000000005757.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum